339 related articles for article (PubMed ID: 29152920)
1. Using State Birth Defects Registries to Evaluate Regional Critical Congenital Heart Disease Newborn Screening.
Case AP; Miller SD; McClain MR
Birth Defects Res; 2017 Nov; 109(18):1414-1422. PubMed ID: 29152920
[TBL] [Abstract][Full Text] [Related]
2. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery.
Johnson LC; Lieberman E; O'Leary E; Geggel RL
Pediatrics; 2014 Nov; 134(5):916-22. PubMed ID: 25287457
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Pulse Oximetry Screening for Critical Congenital Heart Defects after Home Birth and Early Postnatal Discharge.
Narayen IC; Blom NA; van Geloven N; Blankman EIM; van den Broek AJM; Bruijn M; Clur SB; van den Dungen FA; Havers HM; van Laerhoven H; Mir SE; Muller MA; Polak OM; Rammeloo LAJ; Ramnath G; van der Schoor SRD; van Kaam AH; Te Pas AB;
J Pediatr; 2018 Jun; 197():29-35.e1. PubMed ID: 29580679
[TBL] [Abstract][Full Text] [Related]
4. Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects.
Meberg A; Andreassen A; Brunvand L; Markestad T; Moster D; Nietsch L; Silberg IE; Skålevik JE
Acta Paediatr; 2009 Apr; 98(4):682-6. PubMed ID: 19154526
[TBL] [Abstract][Full Text] [Related]
5. Implementing Universal Pulse Oximetry Screening in West Virginia: Findings from Year One.
John C; Phillips J; Hamilton C; Lastliger A
W V Med J; 2016; 112(4):42-6. PubMed ID: 27491102
[TBL] [Abstract][Full Text] [Related]
6. Results from the New Jersey statewide critical congenital heart defects screening program.
Garg LF; Van Naarden Braun K; Knapp MM; Anderson TM; Koppel RI; Hirsch D; Beres LM; Sweatlock J; Olney RS; Glidewell J; Hinton CF; Kemper AR
Pediatrics; 2013 Aug; 132(2):e314-23. PubMed ID: 23858425
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Screening Program to Detect Critical Congenital Heart Defects in Newborns.
Klausner R; Shapiro ED; Elder RW; Colson E; Loyal J
Hosp Pediatr; 2017 Apr; 7(4):214-218. PubMed ID: 28250095
[TBL] [Abstract][Full Text] [Related]
8. Pulse oximetry findings in newborns with antenatally diagnosed congenital heart disease.
Mawson IE; Babu PL; Simpson JM; Fox GF
Eur J Pediatr; 2018 May; 177(5):683-689. PubMed ID: 29404717
[TBL] [Abstract][Full Text] [Related]
9. State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.
Glidewell J; Olney RS; Hinton C; Pawelski J; Sontag M; Wood T; Kucik JE; Daskalov R; Hudson J;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):625-30. PubMed ID: 26086632
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in survival among infants with critical congenital heart defects.
Oster ME; Lee KA; Honein MA; Riehle-Colarusso T; Shin M; Correa A
Pediatrics; 2013 May; 131(5):e1502-8. PubMed ID: 23610203
[TBL] [Abstract][Full Text] [Related]
11. Pulse oximetry screening in Wisconsin.
Beissel DJ; Goetz EM; Hokanson JS
Congenit Heart Dis; 2012; 7(5):460-5. PubMed ID: 22494499
[TBL] [Abstract][Full Text] [Related]
12. Early screening for critical congenital heart defects in asymptomatic newborns in Bursa province.
Özalkaya E; Akdağ A; Şen I; Cömert E; Melek Yaren H
J Matern Fetal Neonatal Med; 2016; 29(7):1105-7. PubMed ID: 25902399
[TBL] [Abstract][Full Text] [Related]
13. Pulse Oximetry Screening Has Not Changed Timing of Diagnosis or Mortality of Critical Congenital Heart Disease.
Campbell MJ; Quarshie WO; Faerber J; Goldberg DJ; Mascio CE; Blinder JJ
Pediatr Cardiol; 2020 Jun; 41(5):899-904. PubMed ID: 32107587
[TBL] [Abstract][Full Text] [Related]
14. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.
Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ;
Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259
[TBL] [Abstract][Full Text] [Related]
15. Pulse Oximetry Screening for Critical Congenital Heart Defects.
Wood J
Neonatal Netw; 2015; 34(3):156-64. PubMed ID: 26802391
[TBL] [Abstract][Full Text] [Related]
16. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.
Peterson C; Ailes E; Riehle-Colarusso T; Oster ME; Olney RS; Cassell CH; Fixler DE; Carmichael SL; Shaw GM; Gilboa SM
JAMA Pediatr; 2014 Apr; 168(4):361-70. PubMed ID: 24493342
[TBL] [Abstract][Full Text] [Related]
17. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.
Knowles R; Griebsch I; Dezateux C; Brown J; Bull C; Wren C
Health Technol Assess; 2005 Nov; 9(44):1-152, iii-iv. PubMed ID: 16297355
[TBL] [Abstract][Full Text] [Related]
18. Trends in Delayed Diagnosis of Critical Congenital Heart Defects in an Era of Enhanced Screening, 2004-2018.
Liberman RF; Heinke D; Lin AE; Nestoridi E; Jalali M; Markenson GR; Sekhavat S; Yazdy MM
J Pediatr; 2023 Jun; 257():113366. PubMed ID: 36858148
[TBL] [Abstract][Full Text] [Related]
19. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics.
Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ;
Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.
Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH
Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
